
ALC Stock Forecast & Price Target
ALC Analyst Ratings
Bulls say
Alcon is poised for a positive financial outlook as it is expected to experience improved top-line growth and significant operating margin expansion moving into FY26. The company’s new product offerings, including Ocular Health products and advanced surgical equipment, are anticipated to drive share gains and contribute to accelerated growth. Additionally, the potential for earnings per share growth in the mid-teens could support Alcon’s premium valuation in the market.
Bears say
Alcon faces a myriad of risks that could hinder its growth, including potential economic downturns that may lead to slower expansion in its over-the-counter (OTC) segments and delays in product rollouts. Additionally, a weaker-than-expected uptake of new products alongside significant competition is anticipated to result in growth falling below the company's target range of 6% to 8%. Furthermore, external factors such as China-based value-based pricing, tariffs, and foreign exchange headwinds could exacerbate these challenges, affecting the company's overall financial performance.
This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.
ALC Analyst Forecast & Price Prediction
Start investing in ALC
Order type
Buy in
Order amount
Est. shares
0 shares